|
|
kidney development
|
GO:0001822 |
213 |
0.366
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.248
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.201
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.169
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.167
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.156
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.155
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.149
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.144
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.133
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.125
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.102
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.096
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.095
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.093
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.092
|
|
|
|
sympathetic neuron projection extension
|
GO:0097490 |
4 |
0.085
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.083
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.080
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.078
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.074
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.074
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.073
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.072
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.072
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.069
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.067
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.067
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.066
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.066
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.065
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.064
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.061
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.059
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.059
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.058
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.057
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.057
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.056
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.053
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.053
|
|
|
|
smooth muscle cell chemotaxis
|
GO:0071670 |
2 |
0.052
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.051
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.051
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.050
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.050
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.049
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.049
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.049
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.048
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.048
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.048
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.046
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.046
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.046
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.046
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.045
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.045
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.045
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.045
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.044
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.043
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.043
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.043
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.043
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.043
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.042
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.042
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.042
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.042
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.041
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.041
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.041
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.040
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.040
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.040
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.040
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.040
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.040
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.040
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.040
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.040
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.039
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.039
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.039
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.039
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.038
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.038
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.038
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.038
|
|
|
|
hypothalamus gonadotrophin releasing hormone neuron development
|
GO:0021888 |
4 |
0.038
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.038
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.037
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.037
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.037
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.037
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.037
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.036
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.036
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.036
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.036
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.035
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.035
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.035
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.034
|
|
|
|
substrate dependent cerebral cortex tangential migration
|
GO:0021825 |
3 |
0.034
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.034
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.034
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.033
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.033
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.033
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.033
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.033
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.033
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.033
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.032
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.032
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.032
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.032
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.032
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.032
|
|
|
|
cerebral cortex tangential migration using cell axon interactions
|
GO:0021824 |
3 |
0.032
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.032
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.031
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.031
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.031
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.031
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.031
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.031
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.031
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.030
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.030
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.030
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.030
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.030
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.030
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.030
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.030
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.029
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.029
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.029
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.029
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.029
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.028
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.028
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.028
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.028
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.028
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.028
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.028
|
|
|
|
neuron projection extension involved in neuron projection guidance
|
GO:1902284 |
14 |
0.028
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.027
|
|
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.027
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.027
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.027
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.027
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.027
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.027
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.027
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.027
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.027
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.027
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.027
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.027
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.026
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.026
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.026
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.026
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.026
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.026
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.026
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.026
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.026
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.026
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.026
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.026
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.026
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.026
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.026
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.025
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.025
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.025
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.025
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.025
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.025
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.025
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.025
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.025
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.025
|
|
|
|
regulation of neuron migration
|
GO:2001222 |
22 |
0.025
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.025
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.025
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.025
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.024
|
|
|
|
gonadotrophin releasing hormone neuronal migration to the hypothalamus
|
GO:0021828 |
3 |
0.024
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.024
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.024
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.024
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.024
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.024
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.024
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.024
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.024
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.024
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.024
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.023
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.023
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.023
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.023
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.023
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.023
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.023
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.023
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.023
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.023
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.023
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.023
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.023
|
|
|
|
neuroblast division in subventricular zone
|
GO:0021849 |
2 |
0.023
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.023
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.023
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.022
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.022
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.022
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.022
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.022
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.022
|
|
|
|
ventral trunk neural crest cell migration
|
GO:0036486 |
4 |
0.022
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.022
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.022
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.022
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.022
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.022
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.022
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.022
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.022
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.022
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.022
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.022
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.022
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.021
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.021
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.021
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.021
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.021
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.021
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.021
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.021
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.021
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.021
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.021
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.021
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.021
|
|
|
|
substrate dependent cell migration
|
GO:0006929 |
18 |
0.021
|
|
|
|
hypothalamus gonadotrophin releasing hormone neuron differentiation
|
GO:0021886 |
4 |
0.021
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.020
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.020
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.020
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.020
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.020
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.020
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.020
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.020
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.020
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.020
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.020
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.020
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.020
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.020
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.020
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.020
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.020
|
|
|
|
heterophilic cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0007157 |
20 |
0.020
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.020
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.020
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.020
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.020
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.019
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.019
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.019
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.019
|
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
26 |
0.019
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.019
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.019
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.019
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.019
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.019
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.019
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.019
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.019
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.019
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.019
|
|
|
|
homophilic cell adhesion via plasma membrane adhesion molecules
|
GO:0007156 |
18 |
0.019
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.019
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.019
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.018
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.018
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.018
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.018
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.018
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.018
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.018
|
|
|
|
regulation of pigment cell differentiation
|
GO:0050932 |
7 |
0.018
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.018
|
|
|
|
adherens junction organization
|
GO:0034332 |
28 |
0.018
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.018
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.018
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.018
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.018
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.018
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.018
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.017
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.017
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.017
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.017
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.017
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.017
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.017
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.017
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.017
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.017
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.017
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
18 |
0.017
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.017
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.017
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.017
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.017
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.017
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.017
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.017
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.017
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.017
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.017
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.017
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.017
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.017
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.017
|
|
|
|
learning
|
GO:0007612 |
98 |
0.017
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.017
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.016
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.016
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.016
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.016
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.016
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.016
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.016
|
|
|
|
facioacoustic ganglion development
|
GO:1903375 |
3 |
0.016
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.016
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.016
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.016
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.016
|
|
|
|
neuron recognition
|
GO:0008038 |
25 |
0.016
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.016
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.016
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.016
|
|
|
|
regulation of melanocyte differentiation
|
GO:0045634 |
7 |
0.016
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.016
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.016
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.016
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.015
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.015
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.015
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.015
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.015
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.015
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.015
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.015
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.015
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.015
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.015
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.015
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.015
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.015
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.015
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.015
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.015
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.015
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.015
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.015
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.015
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.015
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.014
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.014
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.014
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.014
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.014
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.014
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.014
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.014
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.014
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.014
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.014
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.014
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.014
|
|
|
|
negative chemotaxis
|
GO:0050919 |
14 |
0.014
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.014
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.014
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.014
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.014
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.014
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.014
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.014
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.014
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.014
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.014
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.013
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.013
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.013
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.013
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.013
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.013
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.013
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.013
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.013
|
|
|
|
photoreceptor cell morphogenesis
|
GO:0008594 |
3 |
0.013
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.013
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.013
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.013
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.013
|
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.013
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.013
|
|
|
|
regulation of developmental pigmentation
|
GO:0048070 |
14 |
0.013
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.013
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.013
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.013
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.013
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.013
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.013
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.013
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.013
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.013
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.013
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.013
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.013
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.013
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.013
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.013
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.013
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.013
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.013
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.013
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.012
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.012
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.012
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.012
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.012
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.012
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.012
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.012
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.012
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.012
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.012
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.012
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.012
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.012
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.012
|
|
|
|
developmental pigmentation
|
GO:0048066 |
40 |
0.012
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.012
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.012
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.012
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.012
|
|
|
|
negative regulation of smooth muscle cell migration
|
GO:0014912 |
2 |
0.012
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.012
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.012
|
|
|
|
axon extension involved in axon guidance
|
GO:0048846 |
14 |
0.012
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.012
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.012
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.012
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.012
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.012
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.012
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.012
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.012
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.012
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.012
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.012
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.012
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.012
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.012
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.012
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.012
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.012
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.012
|
|
|
|
vegf activated neuropilin signaling pathway
|
GO:0038190 |
2 |
0.012
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.012
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.012
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.012
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.012
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.012
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.012
|
|
